China Longyi Group Intl Hldgs L (OTC:CGYG)

WEB NEWS

Thursday, May 19, 2016

Comments & Business Outlook
CHINA LONGYI GROUP INTERNATIONAL HOLDINGS LIMITED 
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

    Three months ended  
    March 31,  
    2016     2015  
Revenues            
 Sales $  16,466   $  3,560  
 Cost of sales   16,466     4,165  
     Gross margin   -     (605 )
Operating expenses            
 General and administrative expenses   103,486     139,143  
    103,486     139,143  
Loss from operations   (103,486 )   (139,748 )
Other income (expense)            
 Interest income   7     19  
 Other income (expense)   25,273     -  
 Transaction exchange gain   (2,828 )   1,322  
 Interest expense   (5,860 )   -  
    16,592     1,341  
     Loss before income tax expense and noncontrolling interest   (86,894 )   (138,407 )
 Income tax expense   -     -  
Net loss   (86,894 )   (138,407 )
     Less: Net loss attributable to noncontrolling interest   7,517     7,415  
Net loss attributable to China Longyi $  (79,377 ) $  (130,992 )
             
Basic and diluted loss per share $  (0.00 ) $  (0.00 )
Weighted average number of shares outstanding-basic and diluted   77,655,862     77,655,862  
Comprehensive loss            
 Net loss $  (86,894 ) $  (138,407 )
 Foreign currency translation adjustment   (1,506 )   424  
Comprehensive loss   (88,400 )   (137,983 )
Comprehensive loss attributable to noncontrolling interest   (8,244 )   (6,815 )
Comprehensive loss attributable to China Longyi $  (80,156 ) $  (131,168 )

Thursday, April 14, 2016

Comments & Business Outlook

CHINA LONGYI GROUP INTERNATIONAL HOLDINGS LIMITED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

    Twelve months ended  
    December 31,  
    2015     2014  
Revenues            
 Sales $  160,349   $  107,566  
 Cost of sales   236,725     192,027  

     Gross margin

  (76,376 )   (84,461 )
Operating expenses            
 General and administrative expenses   516,912     486,758  
 Goodwill impairment loss            
 Write-off inventory and bus licenses            
 Research and development costs   -     -  
    516,912     486,758  
Loss from operations   (593,288 )   (571,219 )
Other income (expense)            
 Interest income   64     60  
 Other income (expense)   236,748     179,826  
 Transaction exchange gain   (14,110 )   (5,042 )
 Gain on asset disposal            
 Gain on debt settlement            
 Gain on disposal subsidiary            
 Interest expense            
    222,702     174,844  

          noncontrolling interest

  (370,586 )   (396,375 )
 Income tax expense   -     -  
Net loss   (370,586 )   (396,375 )
             
Less: Net loss attributable to noncontrolling interest   27,854     29,140  
Net loss attributable to China Longyi $  (342,732 ) $  (367,235 )
             
Basic and diluted loss per share $  (0.00 ) $  (0.00 )
Weighted average number of
shares outstanding-basic and diluted
  77,655,862     77,655,862  
Comprehensive loss            
 Net loss $  (370,586 ) $  (396,375 )
 Foreign currency translation adjustment   49,252     4,215  
             
Comprehensive loss   (321,334 )   (392,160 )
Comprehensive loss attributable to noncontrolling interest   (20,446 )   (28,964 )
Comprehensive loss attributable to China Longyi $  (300,888 ) $  (363,196 )

Thursday, April 7, 2016

Auditor trail

ITEM 4.01  CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT. 

(a) Dismissal of Previous Independent Registered Public Accounting Firm.
 

  (i) On April 7, 2016, China Longyi Group International Holdings Limited (the “Company”) dismissed its independent registered public accounting firm, Tao Su, CPA (“Tao Su”). The dismissal of Tao Su was approved by the board of directors of the Company.
 
 
  (ii) During the Company’s two most recent fiscal years (ended December 31, 2015 and 2014) and during the subsequent interim period through April 7, 2016, (a) there were no disagreements with Tao Su on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Tao Su, would have caused it to make reference to the subject matter of the disagreements in connection with its reports on the financial statements for such periods and (b) there were no “reportable events” as described in Item 304(a)(1)(v) of Regulation S-K.
 
 
  (v) On April 7, 2016 the Company provided Tao Su with a copy of this Current Report and has requested that it furnish the Company with a letter addressing to the U.S. Securities and Exchange Commission stating whether it agrees with the above statements. A copy of such letter is attached as Exhibit 16.1 to this Current Report on Form 8-K.
 

(b) Engagement of New Independent Registered Public Accounting Firm
 

On April 7, 2016, concurrent with the dismissal of Tao Su, the Company, upon the board of directors’ approval, engaged Anton & Chia LLP. (“Anton & Chia”) as its new independent registered public accounting firm to audit and review the Company’s financial statements effective immediately.

During the Company’s two most recent fiscal years ended December 31, 2015 and 2014 and through the subsequent interim period to April 7, 2016, the Company did not consult Anton & Chia with respect to (a) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and neither a written report was provided to the Company or oral advice was provided that Anton & Chia concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (b) any matter that was the subject of either a disagreement as defined in Item 304(a)(1)(iv) of Regulation S-K or a reportable event as described in Item 304(a)(1)(v) of Regulation S-K.


Friday, November 13, 2015

Comments & Business Outlook

CHINA LONGYI GROUP INTERNATIONAL HOLDINGS LIMITED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

 

  Three months ended     Nine months ended  

 

  September 30,     September 30,  

 

  2015     2014     2015     2014  

Revenues

                       

 Sales

$  153,976     -   $  163,119     -  

 Cost of sales

  185,308     -     206,167     -  

     Gross margin

  (31,332 )   -     (43,048 )   -  

Operating expenses

                       

 General and administrative expenses

  121,637     105,066     363,965     367,795  

 Goodwill impairment loss

  -     -     -     -  

 Write-off inventory and bus licenses

  -     -     -     -  

 Research and development costs

  -           -     -  

 

  121,637     105,066     363,965     367,795  

Loss from operations

  (152,969 )   (105,066 )   (407,013 )   (367,795 )

Other income (expense)

                       

 Interest income

  6     9     55     16  

 Other income (expense)

  179,750     1,730     193,710     5,202  

 Transaction exchange gain

  (10,089 )   (14,988 )   (4,786 )   (15,900 )

 Gain on asset disposal

  -     -     -     -  

 Gain on debt settlement

  -     -     -     -  

 Gain on disposal subsidiary

  -     -     -     -  

 Interest expense

  -           -     -  

 

  169,667     (13,249 )   188,979     (10,682 )

     Loss before income tax expense and noncontrolling interest

  16,698     (118,315 )   (218,034 )   (378,477 )

 Income tax expense

  -     -     -     -  

Net loss

  16,698     (118,315 )   (218,034 )   (378,477 )

     Less: Net loss attributable to noncontrolling interest

  (1,789 )   8,151     13,485     23,789  

Net loss attributable to China Longyi

$  14,909   $  (110,164 ) $  (204,549 ) $  (354,688 )

 

                       

Basic and diluted loss per share

$  0.00   $  (0.00 ) $  (0.00 ) $  (0.00 )

Weighted average number of shares outstanding-basic and diluted

  77,655,862     77,655,862     77,655,862     77,655,862  

Comprehensive loss

                       

 Net loss

$  16,698   $  (118,315 ) $  (218,034 ) $  (378,477 )

 Foreign currency translation adjustment

  32,528     26,938     26,106     17,642  

Comprehensive loss

  49,226     (91,377 )   (191,928 )   (360,835 )

Comprehensive loss attributable to noncontrolling interest

  6,352     (8,151 )   (8,950 )   (23,037 )

Comprehensive loss attributable to China Longyi

$ 42,874   $ (83,226 ) $ (182,978 ) $ (337,798 )

Management Discussion and Analysis

Revenues. Our revenues were historically derived primarily from sales of our SOD products. Revenues increased $153,976, to $153,976 for the three months ended September 30, 2015, from $0 for the same period in 2014. The increase in revenues was due to SOD products being sold in 2015 as compared with the same period of 2014. During the third quarter of 2015, we sold SOD Fruit Enzymes produced in our Henan Tian Jie Shan factory while during the same period of 2014 we did not sell any products.

Net Income (Loss) attributable to China Longyi. As a result of above facts, our net income increased by $125,073, or 113.53%, to $14,909 for the three months ended September 30, 2015, from a net loss of $(110,164) for the same period in 2014.


Friday, August 14, 2015

Comments & Business Outlook

CHINA LONGYI GROUP INTERNATIONAL HOLDINGS LIMITED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

    Six months ended     Three months ended  
    June 30,     June 30,  
    2015     2014     2015     2014  
Revenues                        
 Sales $  9,143   $  -   $  5,583   $  -  
 Cost of sales   10,697     -     6,532     -  
     Gross margin   (1,554 )   -     (949 )   -  
Operating expenses                        
 General and administrative expenses   242,328     262,729     103,185     134,152  
 Goodwill impairment loss   -     -     -     -  
 Write-off inventory and bus licenses   -     -     -     -  
 Research and development costs   -     -     -     -  
    242,328     262,729     103,185     134,152  
Loss from operations   (243,882 )   (262,729 )   (104,134 )   (134,152 )
Other income (expense)                        
 Interest income   49     7     30     3  
 Other income (expense)   13,960     3,472     13,960     629  
 Transaction exchange gain   5,303     (912 )   3,981     7,196  
 Gain on asset disposal   -     -     -     -  
 Gain on debt settlement   -     -     -     -  
 Gain on disposal subsidiary   -     -     -     -  
 Interest expense   -     -     -     -  
    19,312     2,567     17,971     7,828  
    Loss before income tax expense and noncontrolling interest   (224,570 )   (260,162 )   (86,163 )   (126,324 )
 Income tax expense   -     -     -     -  
Net loss   (224,570 )   (260,162 )   (86,163 )   (126,324 )
    Less: Net loss attributable to noncontrolling interest   15,274     15,638     7,859     8,184  
Net loss attributable to China Longyi $  (209,296 ) $  (244,524 ) $  (78,304 ) $  (118,140 )
                         
Basic and diluted loss per share $  (0.00 ) $  (0.00 ) $  (0.00 ) $  (0.00 )
Weighted average number of shares outstanding-basic and diluted   77,655,862     77,655,862     77,655,862     77,655,862  
Comprehensive loss                        
 Net loss $  (224,570 ) $  (260,162 ) $  (86,163 ) $  (126,324 )
 Foreign currency translation adjustment   (6,422 )   2,443     2,874     11,739  
Comprehensive loss   (230,992 )   (257,719 )   (83,289 )   (114,585 )
Comprehensive loss attributable to noncontrolling interest   (15,302 )   (14,876 )   (7,859 )   (8,184 )
Comprehensive loss attributable to China Longyi $  (215,690 ) $  (242,843 ) $  (75,430 ) $  (106,401 )

Management Discussion and Analysis

Revenues. Our revenues were historically derived primarily from sales of our SOD products. Revenues increased $5,583, to $5,583 for the three months ended June 30, 2015, from $0 for the same period in 2014. The increase in revenues was due to more SOD products being sold in 2015 as compare with same period of 2014. During the second quarter of 2015, we sold SOD Fruit Enzymes produced in our Guizhou Tian Jieshan factory as compared with the same period of 2014, in which we did not sell any products.

Net Loss attributable to China Longyi. As a result of above facts, our net loss decreased by $39,836, or 33.72%, to $(78,304) for the three months ended June 30, 2015, from $(118,140) for the same period in 2014.


Friday, May 15, 2015

Comments & Business Outlook

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

 

  Three months ended  

 

  March 31,  

 

  2015     2014  

Revenues

           

   Sales

$  3,560   $  -  

   Cost of sales

  4,165     -  

      Gross margin

  (605 )   -  

Operating expenses

           

General and administrative expenses

  139,143     128,577  

 

  139,143     128,577  

Loss from operations

  (139,748 )   (128,577 )

Other income (expense)

           

   Interest income

  19     4  

   Other income (expense)

  -     2,843  

   Transaction exchange gain

  1,322     (8,108 )

 

  1,341     (5,261 )

      Loss before income tax expense and noncontrolling interest

  (138,407 )   (133,838 )

   Income tax expense

  -     -  

Net loss

  (138,407 )   (133,838 )

Less: Net loss attributable to noncontrolling

  7,415     7,454  

Net loss attributable to China Longyi

$  (130,992 ) $  (126,384 )

 

           

Basic and diluted loss per share

$  (0.00 ) $  (0.00 )

Weighted average number of shares outstanding-basic and diluted

  77,655,862     77,655,862  

Comprehensive loss

           

Net loss

$  (138,407 ) $  (133,838 )

Foreign currency translation adjustment

  424     9,830  

Comprehensive loss

  (137,983 )   (124,008 )

Comprehensive loss attributable to noncontrolling interest

  (6,815 )   (8,289 )

Comprehensive loss attributable to China Longyi

$  (131,168 ) $  (115,719 )

Management Discussion and Analysis

Revenues. Our revenues were historically derived primarily from sales of our SOD products. Revenues increased $3,560, to $3,560 for the three months ended March 31, 2015, from $0 for the same period in 2014.The increase in revenues was due to more SOD products sold in the first quarter of 2015 as compare with same period of 2014. We produced SOD Fruit Enzymes as our new product in Guizhou, and we built the new factory in Tian Jieshan of Guizhou. During the spring festival of 2015, we held promotion events in order to introduce new SOD products, and sold some new products to our selected customers at a price that we believe competitive.

Net Loss attributable to China Longyi. As a result of above facts, our net loss increased by $4,608, or 3.65%, to $130,992 for the three months ended March 31, 2015, from $(126,384) for the same period in 2014.


Friday, November 14, 2014

Comments & Business Outlook

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

    Nine months ended     Three months ended     Period from Jun 4,1997  
    September 30,     September 30,     (inception) to  
    2014     2013     2014     2013     September 30, 2014  
Revenues                              
 Sales $  -   $  11,095   $  -   $  680   $  1,027,204  
 Cost of sales   -     7,409     -     406   $  1,040,259  
Gross margin   -     3,686     -     274   $  (13,055 )
Operating expenses                              
 General and administrative expenses   367,795     366,165     105,066     99,751   $  19,571,638  
 Goodwill impairment loss   -     -     -     -   $  5,408,584  
 Write-off inventory and bus licenses   -     -     -     -   $  3,322,712  
 Research and development costs   -     -     -         $  8,880,206  
    367,795     366,165     105,066     99,751   $  37,183,140  
Loss from operations   (367,795 )   (362,479 )   (105,066 )   (99,477 ) $  (37,196,195 )
Other income (expense)                              
 Interest income   16     23     9     (8 ) $  325,703  
 Other income (expense)   5,202     -     1,730     -   $  1,253,413  
 Transaction exchange gain   (15,900 )   21,404     (14,988 )   1,738   $  1,073,983  
 Gain on asset disposal   -     -     -     -   $  1,172  
 Gain on debt settlement   -     -     -     -   $  156,018  
 Gain on disposal subsidiary   -     -     -     -   $  4,093,455  
 Interest expense   -     -     -         $  (712,302 )
    (10,682 )   21,427     (13,249 )   1,730   $  6,191,442  
Loss before income tax expense and noncontrolling interest   (378,477 )   (341,052 )   (118,315 )   (97,747 ) $  (31,004,753 )
 Income tax expense   -     -     -     -   $  -  
Net loss   (378,477 )   (341,052 )   (118,315 )   (97,747 ) $  (31,004,753 )
Less: Net loss attributable to noncontrolling interest   23,789     28,912     8,151     (9,563 ) $  363,125  
Net loss attributable to China Longyi $  (354,688 ) $  (312,140 ) $  (110,164 ) $  (107,310 ) $  (30,641,628 )
                               
Basic and diluted loss per share $  (0.00 ) $  (0.00 ) $  (0.00 ) $  (0.00 )      
Weighted average number of shares outstanding-basic and diluted   77,655,862     77,655,862     77,655,862     77,655,862        
Comprehensive loss                              
 Net loss $  (378,477 ) $  (341,052 ) $  (118,315 ) $  (97,747 ) $  (31,004,753 )
 Foreign currency translation adjustment   17,642     (18,465 )   26,938     (1,791 )      
Comprehensive loss   (360,835 )   (359,517 )   (91,377 )   (99,538 )      
Comprehensive loss attributable to noncontrolling interest   (23,037 )   (29,903 )   (8,151 )   (9,760 )      
Comprehensive loss attributable to China Longyi $  (337,798 ) $  (329,614 ) $  (83,226 ) $  (89,778 )      

Management Discussion and Analysis

Revenues. Our revenues were historically derived primarily from sales of our SOD products. Revenues decreased $680, to $0 for the three months ended September 30, 2014, from $680 for the same period in 2013 as we did not sell any SOD products and our operating subsidiary, Chongqing SOD, ceased production and was in the process of the relocation.

Net Loss attributable to China Longyi. As a result of above facts, our net loss increased by $2,854, or 2.66%, to $(110,164) for the three months ended September 30, 2014, from $(107,310) for the same period in 2013.


Monday, August 11, 2014

Comments & Business Outlook
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

 

  Six months ended     Three months ended     June 4,1997  

 

  June 30,     June 30,     (inception) to  

 

  2014     2013     2014     2013     June 30, 2014  

Revenues

                             

   Sales

$  -   $  10,415   $  -   $  815   $  1,027,204  

   Cost of sales

  -     7,003     -     275   $  1,040,259  

      Gross margin

  -     3,412     -     540   $  (13,055 )

Operating expenses

                             

   General and administrative expenses

  262,729     266,414     134,152     167,752   $  19,466,572  

   Goodwill impairment loss

  -     -     -     -   $  5,408,584  

   Write-off inventory and bus licenses

  -     -     -     -   $  3,322,712  

   Research and development costs

  -     -     -         $  8,880,206  

 

  262,729     266,414     134,152     167,752   $  37,078,074  

Loss from operations

  (262,729 )   (263,002 )   (134,152 )   (167,212 ) $  (37,091,129 )

Other income (expense)

                             

   Interest income

  7     15     3     (9 ) $  325,694  

   Other income (expense)

  3,472     -     629     -   $  1,251,683  

   Transaction exchange gain

  (912 )   19,666     7,196     34,289   $  1,088,971  

   Gain on asset disposal

  -     -     -     -   $  1,172  

   Gain on debt settlement

  -     -     -     -   $  156,018  

   Gain on disposal subsidiary

  -     -     -     -   $  4,093,455  

   Interest expense

  -     -     -         $  (712,302 )

 

  2,567     19,681     7,828     34,280   $  6,204,691  

      Loss before income tax expense and noncontrolling interest

  (260,162 )   (243,321 )   (126,324 )   (132,932 ) $  (30,886,438 )

   Income tax expense

  -     -     -     -   $  -  

Net loss

  (260,162 )   (243,321 )   (126,324 )   (132,932 ) $  (30,886,438 )

Less: Net loss attributable to noncontrolling

  15,638     19,349     8,184     29,531   $  354,974  

Net loss attributable to China Longyi

$  (244,524 ) $  (223,972 ) $  (118,140 ) $  (103,401 ) $  (30,531,464 )

 

                             

Basic and diluted loss per share

$  (0.00 ) $  (0.00 ) $  (0.00 ) $  (0.00 )      

Weighted average number of shares outstanding-basic and diluted

  77,655,862     77,655,862     77,655,862     77,655,862        

Comprehensive loss

                             

   Net loss

$  (260,162 ) $  (243,321 ) $  (126,324 ) $  (132,932 ) $  (30,886,438 )

   Foreign currency translation adjustment

  2,443     (16,688 )   11,739     (7,392 )      

Comprehensive loss

  (257,719 )   (260,009 )   (114,585 )   (140,324 )      

Comprehensive loss attributable to noncontrolling interest

  (14,876 )   (20,143 )   (8,184 )   (29,531 )      

Comprehensive loss attributable to China Longyi

$  (242,843 ) $  (239,866 ) $  (106,401 ) $  (110,793 )  

Management Discussion and Analysis

Revenues. Our revenues were historically derived primarily from sales of our SOD products. Revenues decreased $815, to $0 for the three months ended June 30, 2014, from $815 for the same period in 2013 as we did not sell any SOD products and our operating subsidiary, Chongqing SOD, ceased production and was in the process of the relocation.

Net Loss attributable to China Longyi. As a result of above factors, our net loss increased by $14,739, or 14.25%, to $(118,140) for the three months ended June 30, 2014, from $(103,401) for the same period in 2013.


Tuesday, May 13, 2014

Comments & Business Outlook
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

 

  Three months ended     Period from June 4,1997  

 

  March 31,     (inception) to  

 

  2014     2013     March 31, 2014  

Revenues

                 

   Sales

$  -   $  9,600   $  1,027,204  

   Cost of sales

  -     6,728   $  1,040,259  

      Gross margin

  -     2,872   $  (13,055 )

Operating expenses

                 

   General and administrative expenses

  128,577     98,662   $  19,332,420  

   Goodwill impairment loss

  -     -   $  5,408,584  

   Write-off inventory and bus licenses

  -     -   $  3,322,712  

   Research and development costs

  -     -   $  8,880,206  

 

  128,577     98,662   $  36,943,922  

Loss from operations

  (128,577 )   (95,790 ) $  (36,956,977 )

Other income (expense)

                 

   Interest income

  4     6   $  325,691  

   Other income (expense)

  2,843     -   $  1,251,054  

   Transaction exchange gain

  (8,108 )   (14,623 ) $  1,081,775  

   Gain on asset disposal

  -     -   $  1,172  

   Gain on debt settlement

  -     -   $  156,018  

   Gain on disposal subsidiary

  -     -   $  4,093,455  

   Interest expense

  -     -   $  (712,302 )

 

  (5,261 )   (14,617 ) $  6,196,863  

      Loss before income tax expense and noncontrolling interest

  (133,838 )   (110,407 ) $  (30,760,114 )

   Income tax expense

  -     -   $  -  

Net loss

  (133,838 )   (110,407 ) $  (30,760,114 )

Less: Net loss attributable to noncontrolling

  7,454     8,876   $  346,790  

Net loss attributable to China Longyi

$  (126,384 ) $  (101,531 ) $  (30,413,324 )

 

                 

Basic and diluted loss per share

$  (0.00 ) $  (0.00 )      

Weighted average number of shares outstanding-basic and diluted

  77,655,862     77,655,862        

Comprehensive loss

                 

   Net loss

$  (133,838 ) $  (110,407 ) $  (30,760,114 )

   Foreign currency translation adjustment

  9,830     15,522        

Comprehensive loss

  (124,008 )   (94,885 )      

Comprehensive loss attributable to noncontrolling interest

  (8,289 )   (8,970 )      

Comprehensive loss attributable to China Longyi

$  (115,719 ) $  (85,915 )      

Management Discussion and Analysis

Revenues. Our revenues were historically derived primarily from sales of our SOD products. Revenues decreased $9,600, to $0 for the three months ended March 31, 2014, from $9,600 for the same period in 2013 as we did not sell any SOD products and our operating subsidiary, Chongqing SOD, ceased production and was in the process of the relocation.

Net Loss attributable to China Longyi. As a result of above facts, our net loss increased by $24,853, or 24.48%, to $(126,384) for the three months ended March 31, 2014, from $(101,531) for the same period in 2013.


Tuesday, April 1, 2014

Comments & Business Outlook
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
(A DEVELOPMENT STAGE COMPANY)
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

  Twelve months ended     Period from June 4, 1997  

 

  December 31,     (inception) to  

 

  2013     2012     December 31, 2013  

Revenues

                 

   Sales

$  58,380   $  256,304   $  1,027,204  

   Cost of sales

  48,086     123,388   $  1,040,259  

   Gross margin

  10,294     132,916   $  (13,055 )

Operating expenses

                 

   General and administrative expenses

  583,410     680,933   $  19,203,843  

   Goodwill impairment loss

  -     -   $  5,408,584  

   Write-off inventory and bus licenses

  -     -   $  3,322,712  

   Research and development costs

  -     -   $  8,880,206  

 

  583,410     680,933   $  36,815,345  

Loss from operations

  (573,116 )   (548,017 ) $  (36,828,400 )

Other income (expense)

                 

   Interest income

  27     1,106   $  325,687  

   Other income (expense)

  84,104     94,545   $  1,248,211  

   Transaction exchange gain

  12,824     30,860   $  1,089,883  

   Gain on asset disposal

  -     -   $  1,172  

   Gain on debt settlement

  -     -   $  156,018  

   Gain on disposal subsidiary

  -     -   $  4,093,455  

   Interest expense

  -     -   $  (712,302 )

 

  96,955     126,511   $  6,202,124  

      Loss before income tax expense and noncontrolling interest

  (476,161 )   (421,506 ) $  (30,626,276 )

   Income tax expense

  -     -   $  -  

Net loss

  (476,161 )   (421,506 ) $  (30,626,276 )

   Less: Net loss attributable to noncontrolling interest

  48,230     49,607   $  339,336  

Net loss attributable to China Longyi

$  (427,931 ) $  (371,899 ) $  (30,286,940 )

 

                 

Basic and diluted loss per share

$  (0.01 ) $  (0.00 )      

Weighted average number of shares outstanding-basic and diluted

  77,655,862     77,655,862        

Comprehensive loss

                 

   Net loss

$  (476,161 ) $  (421,506 )  

 (30,626,276

)

   Foreign currency translation adjustment

  (10,889 )   (26,956 )      

Comprehensive loss

  (487,050 )   (448,462 )      

Comprehensive loss attributable to noncontrolling interest

  (49,909 )   (49,770 )      

Comprehensive loss attributable to China Longyi

$  (437,141 ) $  (398,692 )  

Management Discussion and Analysis

Results of Operations

We are a development stage company. We have only generated limited revenues from our operations since our inception. Before November 12, 2007, we had limited operations and our purpose was to acquire an operating business or the valuable assets of an unidentified company. As a result of the acquisition of Top Time, we changed our business to the development, manufacture and sale of SOD products.

Revenue

Our revenues are derived primarily from sales of our SOD products. Our revenues in fiscal year 2013 amounted to $58,380, which is $197,924 or approximately 77.22% less than that of fiscal year 2012, when we had revenues of $256,304. The decrease in revenues was attributable to fewer products being sold as compared with 2012, which was due to the suspension of our SOD products producing as we are relocating to another region as requested by the government.

Net Income.

As a result of the factors described above, our net loss increased $54,655, or 12.97%, to $(476,161) for the year ended December 31, 2013, from $(421,506) for 2012.


Friday, August 16, 2013

Comments & Business Outlook
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
(A DEVELOPMENT STAGE COMPANY)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

    Six months ended     Three months ended     Period From
June 4,1997
 
    June 30,     June 30,     (inception) to  
    2013     2012     2013     2012     June 30, 2013  
Revenues                              
 Sales $  10,415   $  5,673   $  815   $  2,025   $  979,239  
 Cost of sales   7,003     4,067     275     1,359   $  999,176  
 Gross margin   3,412     1,606     540     666   $  (19,937 )
Operating expenses                              
 General and administrative expenses   266,414     228,842     167,752     146,017   $  18,886,847  
 Goodwill impairment loss   -     -     -     -   $  5,408,584  
 Write-off inventory and bus licenses   -     -     -     -   $  3,322,712  
 Research and development costs   -     -     -         $  8,880,206  
    266,414     228,842     167,752     146,017   $  36,498,349  
Loss from operations   (263,002 )   (227,236 )   (167,212 )   (145,351 ) $  (36,518,286 )
Other income (expense)                              
 Interest income   15     923     (9 )   58   $  325,675  
 Other income (expense)   -     67     -     -   $  1,164,107  
 Transaction exchange gain   19,666     17,683     34,289     7,974   $  1,096,725  
 Gain on asset disposal   -     -     -     -   $  1,172  
 Gain on debt settlement   -     -     -     -   $  156,018  
 Gain on disposal subsidiary   -     -     -     -   $  4,093,455  
 Interest expense   -     -     -         $  (712,302 )
    19,681     18,673     34,280     8,032   $  6,124,850  
   Loss before income tax expense and
     noncontrolling interest
 
(243,321
)  
(208,563
)  
(132,932
)  
(137,319
)  
$ (30,393,436
)
 Income tax expense   -     -     -     -   $  -  
Net loss   (243,321 )   (208,563 )   (132,932 )   (137,319 ) $  (30,393,436 )
 Less: Net loss attributable to noncontrolling
     interest
 
19,349
   
38,079
   
29,531
   
29,531
   
$ 310,455
 
Net loss attributable to China Longyi $  (223,972 ) $  (170,484 ) $  (103,401 ) $  (107,788 ) $  (30,082,981 )
                               
Basic and diluted loss per share $  (0.00 ) $  (0.00 ) $  (0.00 ) $  (0.00 )      
Weighted average number
  of shares outstanding-basic and diluted
 
77,655,862
   
77,655,862
   
77,655,862
   
77,655,862
   
 
Comprehensive loss                              
 Net loss $  (243,321 ) $  (208,563 ) $  (132,932 ) $  (137,319 ) $

   (30,393,436

)
 Foreign currency translation adjustment   (16,688 )   (20,181 )   (7,392 )   (10,885 )      
Comprehensive loss   (260,009 )   (228,744 )   (140,324 )   (148,204 )      
Comprehensive loss attributable to
  noncontrolling interest
 
(20,143
)  
(38,044
)  
(29,531
)  
(29,531
)  
 
Comprehensive loss attributable to China
  Longyi
 
$ (239,866
)  
$ (190,700
)  
$ (110,793
)  
$ (118,673
)  


Market Data powered by QuoteMedia. Terms of Use